Successful Implementation of Nirsevimab and Factors Influencing Uptake in Neonatal Care
Our implementation strategy ensured equitable access to nirsevimab for newborns with both our high uptake and acceptance rate underscoring the effectiveness of our approach. Key strategies for success included early stakeholder engagement, multidisciplinary collaboration, and proactive logistic planning. Our approach serves as a model for other institutions to offer nirsevimab prior to hospital discharge and highlights the importance of addressing both clinical and socioeconomic barriers.
Authors
- Hayden T. Schwenk (ORCID: https://orcid.org/0000-0002-8164-8655)
- Lauren M. Puckett (ORCID: https://orcid.org/0000-0003-1558-2739)
- Lauren E. Kushner (ORCID: https://orcid.org/0000-0003-2626-316X)
- Laura Bio (ORCID: https://orcid.org/0000-0001-9520-6420)
- Matthew Wood (ORCID: https://orcid.org/0000-0003-3974-2282)
- Sean Cornell
Institutions
- Lucile Packard Children's Hospital (US)
- Stanford University (US)
Publication Details
- Journal
- Hospital Pediatrics
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1542/hpeds.2024-008070
- Citations
- 10
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 3.87